Microbot Medical Inc. expects its Liberty system to be the first company to introduce a fully disposable endovascular robotic system in the US in 2023, but still has a long regulatory pathway ahead.
On 31 March Microbot announced it filed its pre-submission package for the Liberty Robotic System with the US Food and Drug Administration and plans to meet with regulators to address
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?